Bide Pharmatech Co. Ltd. A (688073) — Defensive Interval Ratio
Bide Pharmatech Co. Ltd. A (688073) has a Defensive Interval Ratio of 573 days as of March 2026. Defensive assets of CN¥495.62 Million (cash CN¥-, short-term investments CN¥240.38 Million, receivables CN¥255.24 Million) cover 573 days of daily cash needs of CN¥865.51K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bide Pharmatech Co. Ltd. A Defensive Interval Ratio (2020–2025)
This chart shows how Bide Pharmatech Co. Ltd. A's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 573 days, meaning defensive assets of CN¥495.62 Million can fund 573 days of operations without new revenue. For the complete balance sheet picture, see Bide Pharmatech Co. Ltd. A (688073) total assets.
Annual Defensive Interval Ratio for Bide Pharmatech Co. Ltd. A (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bide Pharmatech Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Bide Pharmatech Co. Ltd. A to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (CNY) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 377 days | CN¥353.44 Million | CN¥936.49K/day | CN¥- | CN¥100.01 Million | ▲ +62 days |
| 2024 | 315 days | CN¥298.48 Million | CN¥947.29K/day | CN¥- | CN¥75.52 Million | ▲ +3 days |
| 2023 | 312 days | CN¥235.13 Million | CN¥753.34K/day | CN¥- | CN¥122.54K | ▲ +47 days |
| 2022 | 265 days | CN¥181.00 Million | CN¥682.39K/day | CN¥- | CN¥3.97 Million | ▲ +83 days |
| 2021 | 182 days | CN¥124.68 Million | CN¥683.74K/day | CN¥- | CN¥- | ▼ -143 days |
| 2020 | 326 days | CN¥127.94 Million | CN¥392.93K/day | CN¥- | CN¥43.00 Million | — |